AKT1 and cancer: The findings demonstrated that the expression of markers of epithelial–mesenchymal transition (EMT) and cancer stem cells (CSCs) was dramatically elevated in chemoresistant EOC cells, coupled with the activation of PI3K/Akt/mTOR signaling.